drugset / Trial / NCT07519525
A Study of [14C]-LY4064809 in Healthy Participants
NaSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to determine in healthy participants the percentage of LY4064809 that enters bloodstream after oral administration. Blood tests will be performed to investigate how the body processes the study drug. For each participant, the study will last about 21 days, not including screening. Participants will remain in the clinical research center for 14 days.
Timeline
- Start
- 2026-03-27
- Primary completion
- 2026-05-26
- Completion
- 2026-05-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | STX-478 | Small molecule | — | Oral |
Indications
No indication recorded.